Sprout Health GLP-1 Review: Pricing, Pharmacies, Pros, Cons & What They Don't Tell You

Sprout Health is one of the more visible compounded semaglutide and tirzepatide telehealth platforms in the post-shortage market. Here's a sourced look at what they actually charge, where they ship, who their partner pharmacies are, what real customers report, and where Sprout fits — and doesn't fit — versus the major competitors.

Who Is Sprout Health

Sprout Health Partners LLC is a telehealth platform headquartered in Encinitas, California. It launched in 2023 and operates at joinsprouthealth.com. The company functions as a three-entity model: Sprout Health is the technology and coordination platform; independent licensed clinicians provide medical evaluation and prescribing; and partner compounding pharmacies prepare and dispense the medication. According to Sprout's published terms, the company partners with two compounding pharmacies — Foothills Pharmacy and Promise Pharmacy.

Sprout is LegitScript certified as both a telehealth provider and online pharmacy. LegitScript is an independent verification service that confirms baseline regulatory compliance, licensing status, and business legitimacy. Many smaller compounded GLP-1 platforms do not carry this certification. It does not guarantee quality of service or product, but it confirms the company has cleared a basic regulatory threshold.

Pricing Breakdown (April 2026)

Sprout Health's pricing is publicly disclosed and consistent across third-party reviews:

What's included in the monthly cost: the licensed clinician evaluation, follow-up appointments, asynchronous messaging access, the four-week medication supply (if approved and prescribed), and shipping. There is no separate membership fee. Sprout does not accept insurance and operates as a cash-pay service. HSA/FSA acceptance is not explicitly mentioned on the platform's site; customers should verify with their plan administrator.

The Price-Lock Guarantee

One feature that distinguishes Sprout from many compounded GLP-1 platforms is its price-lock policy: the monthly subscription rate stays the same even as the patient's dose escalates over time. Most GLP-1 providers charge more at higher doses — Sprout does not. For a long-term patient who titrates to maintenance dosing, this becomes a meaningful cost advantage relative to providers with dose-tiered pricing.

Where Sprout Sits on Price

Sprout is neither the cheapest nor the most expensive compounded GLP-1 platform. Comparison points (publicly disclosed pricing as of April 2026):

For a buyer optimizing strictly on monthly price, Sprout is not the leader. The platform's value proposition relies on the price-lock guarantee paying off over a longer treatment course, the LegitScript certification, the availability of both injectable and oral formulations, and the bundled NAD+ option (if relevant).

State Availability

Sprout Health is available in 44 U.S. states. It is not available for GLP-1 medications in:

• Alabama
• Arkansas
• California
• Louisiana
• Mississippi
• North Dakota

The California exclusion is significant — California is the largest U.S. state by population, and the absence reflects a stricter state regulatory environment around telehealth prescribing of compounded medications. NAD+ injections (a separate product line Sprout offers) have a different exclusion list and are not available in Arkansas, Kansas, or New Mexico.

The Clinical Process

Sprout's process is built around minimal friction:

1. Eligibility quiz (2–5 minutes) — Age, weight, weight loss goals, basic health history.
2. Pre-approval decision — Same-day, based on the questionnaire.
3. Payment — First month is charged before the clinician review is completed.
4. Detailed medical questionnaire — More thorough health history submitted to the clinician.
5. Government ID and selfie — Identity verification.
6. Clinician review — A licensed provider reviews the submitted information within 48 hours.
7. Live telehealth visit — Required in some states; in most states, care is provided through asynchronous online chat.
8. Pharmacy fulfillment — If approved, prescription is sent to Foothills Pharmacy or Promise Pharmacy. Shipping in 5–7 business days.

Routine lab work is not required before starting treatment, although a provider may request testing depending on a patient's medical history. This is more permissive than some competing platforms that require baseline labs (typically HbA1c, comprehensive metabolic panel, lipid panel) before issuing a first prescription.

What the Reduced Friction Actually Means

The asynchronous, no-lab-required model has an obvious appeal — it's fast, convenient, and removes a common friction point. It also has tradeoffs. For a patient with undiagnosed comorbidities, baseline labs would surface conditions that affect prescribing decisions (uncontrolled diabetes, kidney function, thyroid status). The asynchronous model also reduces the opportunity for a clinician to identify boxed warning contraindications (personal or family history of medullary thyroid carcinoma, MEN 2) through a back-and-forth conversation. Patients should ensure they affirmatively communicate any concerning history during the questionnaire — the asynchronous model relies on patient-provided information being complete and accurate.

What Customers Report

Customer experience with Sprout, based on reviews aggregated from Trustpilot, Better Business Bureau, and ConsumerAffairs, follows a bimodal pattern: a meaningful share of patients report rapid sign-up, prompt shipping, and effective results; another meaningful share report customer service difficulties, shipping delays, and concerns about formulation potency.

Common positive themes

• Fast sign-up — many patients approved same day, medication arriving within 7–10 days of starting the enrollment process
• The price-lock policy as advertised — patients report monthly costs staying flat through dose escalation
• Multiple formulation options (injectable + tablet) for patients who prefer oral dosing
• Specific Sprout team members named positively in customer service interactions

Common negative themes

• Customer service responsiveness — Multiple ConsumerAffairs and Trustpilot reviews describe difficulty reaching support, particularly by phone
• Shipping delays — Some patients report 2-3+ week delays on later monthly refills versus the advertised 5-7 business days
• Formulation potency concerns — Patients switching from brand-name Wegovy or Zepbound to Sprout's compounded versions have reported significantly reduced appetite suppression and weight regain. One detailed Trustpilot review described losing 45 lbs on Wegovy 2.4 mg and then gaining 5 lbs in one month after switching to Sprout's compounded semaglutide at the recommended unit equivalent.
• Refund difficulty — Sprout's published policy is no refunds once the prescription is sent to the pharmacy

The Affiliate-Site vs. Customer-Review Gap

One pattern worth flagging for any compounded GLP-1 telehealth review: the gap between affiliate review sites (which generate revenue from customer referrals) and direct customer review platforms can be substantial. Many affiliate sites rate Sprout at 4.8+/5; Trustpilot and ConsumerAffairs reviews are noticeably more mixed. This is not unique to Sprout — it is a structural feature of the affiliate-driven telehealth review ecosystem. The honest reading is somewhere in the middle: Sprout works well for many customers, has real customer service problems for others, and is not the best-in-class option on every dimension that matters.

Pros & Cons Summary

Sourceglp-1 Scorecard

Who Sprout Is Best For

Sprout Health is the right fit for a specific patient profile:

• You're starting fresh on a GLP-1 rather than switching from a brand-name product. Patients starting from the lowest titration dose are less likely to encounter the potency-perception issues reported by patients switching from established brand-name doses.
• You expect to be on the medication long-term and titrate to a high maintenance dose. The price-lock guarantee is most valuable when your dose escalates and you would otherwise pay more elsewhere.
• You're comfortable with asynchronous (chat-based) clinical interaction and don't need a live video consultation.
• You value LegitScript certification as a baseline trust signal in a market where many platforms have no third-party verification.
• You're outside California and the other excluded states.
• You want both injection and oral tablet options from a single platform.

Who Sprout Is NOT Best For

• Cost-sensitive buyers. Ro at ~$149/month for either semaglutide or tirzepatide, and Found at ~$129/month for semaglutide, are significantly cheaper.
• Patients who place high value on customer service responsiveness. The complaint patterns are clear and recurring.
• Patients in California, Alabama, Arkansas, Louisiana, Mississippi, or North Dakota.
• Patients switching from established brand-name doses. Reported potency concerns warrant additional caution and ideally a more clinically-engaged platform that can fine-tune dose conversion.
• Patients who want a live initial consultation and a more thorough clinical workup.
• Patients who specifically want FDA-approved brand-name medication. Sprout exclusively dispenses compounded products. For brand-name Wegovy or Zepbound, patients should look to LillyDirect, NovoCare, or telehealth platforms that prescribe brand-name FDA-approved products.

The Compounded GLP-1 Regulatory Context

Any honest review of any compounded GLP-1 platform must include the regulatory backdrop. The FDA-declared shortages of semaglutide and tirzepatide that originally permitted broad compounded distribution have ended (tirzepatide late 2024, semaglutide early 2025). Since then, the FDA has substantially escalated enforcement against compounded GLP-1 telehealth marketing — including, by reporting, issuing 30 warning letters to GLP-1 telehealth companies in March 2026. Patient-specific compounding is intended to remain available in limited circumstances when an FDA-approved drug cannot meet a patient's medical needs (for example, allergy to an excipient in the brand product). Whether the broad mass-market compounded GLP-1 access of the past several years continues in its current form is genuinely uncertain.

Sprout Health is one of many platforms operating in this evolving environment. The platform-level question for any prospective customer is not just "does this provider work today" but "is this provider well-positioned for whatever the regulatory framework looks like 12 months from now."

If Sprout Fits

If you've read this far and Sprout still looks like the right fit — you're a self-sufficient buyer, you value the price-lock, you're outside the excluded states, and you've factored in the customer service tradeoffs — here's the link.

If Sprout Doesn't Fit: Alternatives

If the customer service concerns, pricing, or geographic exclusions rule Sprout out, several alternatives serve overlapping use cases.

Affiliate Disclosure: Some provider links on this page are affiliate links. If you sign up through these links, we may receive compensation at no additional cost to you. This does not influence our editorial content, sourcing standards, or honest assessment of Sprout's strengths and weaknesses. This article is informational only and does not constitute medical advice. Compounded GLP-1 medications are not FDA-approved finished products.